Question 1

How many shares of PRVL does CITADEL ADVISORS LLC own?

Accepted Answer

CITADEL ADVISORS LLC previously held 0 shares of PRVL (PREVAIL THERAPEUTICS INC) before exiting the position in 2021-Q1.

Question 2

What is CITADEL ADVISORS LLC's PRVL position worth?

Accepted Answer

CITADEL ADVISORS LLC's PRVL position was last reported at $0 in 2021-Q1 before the exit.

Question 3

Is CITADEL ADVISORS LLC buying or selling PRVL?

Accepted Answer

In 2021-Q1, CITADEL ADVISORS LLC exited their PRVL position entirely (-100.0% change in shares).

Question 4

When did CITADEL ADVISORS LLC first buy PRVL?

Accepted Answer

Based on available 13F filings, CITADEL ADVISORS LLC first reported a position in PRVL in 2019-Q2. They have held the position across 8 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q1 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2020-Q4	Increased	2.4M	+0.1%	$55.8M	0.0%	—	29
2020-Q3	Increased	2.4M	+105.5%	$24.6M	0.0%	—	46
2020-Q2	Increased	1.2M	+0.2%	$17.5M	0.0%	—	28
2020-Q1	Increased	1.2M	+0.2%	$14.3M	0.0%	—	28
2019-Q4	Increased	1.2M	+9.3%	$18.5M	0.0%	—	31
2019-Q3	Decreased	1.1M	-9.8%	$13.1M	0.0%	—	0
2019-Q2	New	1.2M	-	$15.7M	0.0%	—	39

PRVL8 quarters

PRVL
8 quarters